Clinical Trial Update: Management of Advanced Non-Small Cell Lung Cancer (NSCLC) and Clinical Outcomes in Patients Who Received Gefitinib in Thailand

View source ↗

Summary

A clinical trial update describing management strategies and outcomes for patients with advanced non-small cell lung cancer who received gefitinib in Thailand.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Lung Cancer | Status: COMPLETED